These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34441015)

  • 21. 18F-fluorodeoxyglucose-PET for patients with suspected spondylitis showing Modic change.
    Ohtori S; Suzuki M; Koshi T; Yamashita M; Yamauchi K; Inoue G; Orita S; Eguchi Y; Kuniyoshi K; Ochiai N; Kishida S; Takaso M; Aoki Y; Ishikawa T; Arai G; Miyagi M; Kamoda H; Suzuki M; Nakamura J; Toyone T; Takahashi K
    Spine (Phila Pa 1976); 2010 Dec; 35(26):E1599-603. PubMed ID: 21189482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of vertebral osteomyelitis over an eight-year period: The UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis).
    Russo A; Graziano E; Carnelutti A; Sponza M; Cadeo B; Sartor A; Righi E; Bassetti M
    Int J Infect Dis; 2019 Dec; 89():116-121. PubMed ID: 31629078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of (18)F-FDG PET/CT in inflammation of unknown origin.
    Balink H; Bennink RJ; Veeger NJ; van Eck-Smit BL; Verberne HJ
    Clin Nucl Med; 2014 May; 39(5):419-25. PubMed ID: 24662652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome.
    Yoon SH; Chung SK; Kim KJ; Kim HJ; Jin YJ; Kim HB
    Eur Spine J; 2010 Apr; 19(4):575-82. PubMed ID: 19937064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
    Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
    Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of reliability of inflammatory markers over 18-FDG-PET CT scan in monitoring skull base osteomyelitis.
    Faizal B; Surendran B; Kumar M
    Braz J Otorhinolaryngol; 2022; 88(5):691-700. PubMed ID: 33229289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Antibiotic Treatment Affect the Diagnostic Accuracy of
    Kagna O; Kurash M; Ghanem-Zoubi N; Keidar Z; Israel O
    J Nucl Med; 2017 Nov; 58(11):1827-1830. PubMed ID: 28473596
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes of additional instrumentation in elderly patients with pyogenic vertebral osteomyelitis and previous spinal instrumentation.
    Kim J; Lee JH; Kim SW; Oh JK; Kim YW; Kim TH
    Spine J; 2019 Sep; 19(9):1498-1511. PubMed ID: 31108235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
    Rastogi A; Bhattacharya A; Prakash M; Sharma S; Mittal BR; Khandelwal N; Bhansali A
    Nucl Med Commun; 2016 Dec; 37(12):1253-1259. PubMed ID: 27749777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the Diagnostic Performance of
    Swart LE; Gomes A; Scholtens AM; Sinha B; Tanis W; Lam MGEH; van der Vlugt MJ; Streukens SAF; Aarntzen EHJG; Bucerius J; van Assen S; Bleeker-Rovers CP; van Geel PP; Krestin GP; van Melle JP; Roos-Hesselink JW; Slart RHJA; Glaudemans AWJM; Budde RPJ
    Circulation; 2018 Oct; 138(14):1412-1427. PubMed ID: 30018167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of histopathology and preoperative 18F-FDG-PET/CT of osteomyelitis aiming for image guided surgery: A preliminary trial.
    Takaki M; Takenaka N; Mori K; Harada S; Asahara T; Katoh N; Sakuma H; Saginoya T; Kubota K; Teramoto T; Matsushita T
    Injury; 2020 Apr; 51(4):871-877. PubMed ID: 32143858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of residual disease of spine infection using F-18 FDG PET/CT.
    Kim SJ; Kim IJ; Suh KT; Kim YK; Lee JS
    Spine (Phila Pa 1976); 2009 Oct; 34(22):2424-30. PubMed ID: 19829257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis.
    Allen RT; Lee YP; Stimson E; Garfin SR
    Spine (Phila Pa 1976); 2007 Dec; 32(26):2996-3006. PubMed ID: 18091493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases.
    Kälicke T; Schmitz A; Risse JH; Arens S; Keller E; Hansis M; Schmitt O; Biersack HJ; Grünwald F
    Eur J Nucl Med; 2000 May; 27(5):524-8. PubMed ID: 10853807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.